Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations-Reference-Cited by-同舟云学术

Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations

Published:2017-05-26 Issue:9 Volume:114 Page:2043-2056
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnol. Bioeng.

Author:

Yang Yang¹^ORCID,Velayudhan Ajoy²,Thornhill Nina F.¹,Farid Suzanne S.²

Affiliation:

1. Centre for Process Systems Engineering, Department of Chemical Engineering; Imperial College London, South Kensington Campus; London SW7 2AZ UK

2. The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering; University College London, Torrington Place; London WC1E 7JE UK

Funder

Engineering and Physical Sciences Research Council

Consortium of Industrial and Governmental Users

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bit.26329/fullpdf

Reference33 articles.

1. Theory of protein solubility;Arakawa;Methods Enzymol,1985

2. Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: Role of conformational and colloidal stability;Goldberg;J Pharm Sci,2011

3. Classification of EEG spatial patterns with a tree-structured methodology − CART;Grajski;IEEE Trans Biomed Eng,1986

4. Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies;Harris;Drug Dev Res,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concentration-Dependent Diffusion of Monoclonal Antibodies: Underlying Mechanisms of Anomalous Diffusion;Molecular Pharmaceutics;2024-04-04

2. Next-generation cell line selection methodology leveraging data lakes, natural language generation and advanced data analytics;Frontiers in Bioengineering and Biotechnology;2023-06-05

3. Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study;Transfusion;2023-04-29

4. Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks;mAbs;2023-01-27

5. Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics;Antibody Therapeutics;2022-11-11